Presentation is loading. Please wait.

Presentation is loading. Please wait.

Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015.

Published byLogan Walker Modified over 8 years ago

Similar presentations

Presentation on theme: "Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015."— Presentation transcript:

1 Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015

2 © 2014 Virginia Mason Objectives Review current trends in recipient and donor populations. Review donor and transplant trends at Virginia Mason over the past 5 years Review the use of unconventional donors in our program 2

3 © 2014 Virginia Mason Need As of 07:12AM 03/05/15: –101,585 patients on the kidney waitlist 16,894 total transplants in 2013 –11,161 Deceased donor –5,733 living donor –13,124 Jan-Nov 2014 15-20% Dialysis patients die annually Wolfe et al. NEJM, 1999 OPTN data

4 © 2014 Virginia Mason Need 2011 OPTN Annual Report

5 © 2014 Virginia Mason Need 2011 OPTN Annual Report

6 © 2014 Virginia Mason Recipient Age OPTN Data

7 © 2014 Virginia Mason Expanded Recipient Population Older recipients Recipients with higher immunologic risk Desensitization HIV positive recipients

8 © 2014 Virginia Mason Need Renal Transplantation is safe –Survival advantage –Quality of life Recipient age and complexity are increasing Organ supply is not Port et al. JAMA, 1993 Russel et al. Transplantation, 1992

9 © 2014 Virginia Mason 9

10 Use of Unconventional Donors 10

11 © 2014 Virginia Mason Use of Unconventional Donors 11

12 © 2014 Virginia Mason Outcomes 12

13 © 2014 Virginia Mason ECD/KDPI >85% Donor –67 yo female fall from ladder –KDPI 94% –CDC increased risk - hemodilution –Height 5'5'' Weight 50kg, BMI 18 –Terminal creat 1.4 (Admit 0.9) –Biopsy shows 5-15% sclerosis 13 Recipient –70-year-old female –CPRA 0% –53 kg –CKD V 2/2 DM

14 © 2014 Virginia Mason ECD/KDPI >85% 2 for 1-Dual grafts 3mg/kg thymo induction Low intensity belatacept protocol (mmf, pred 5) Early BK Nephropathy-Resolved Creat Nadir 1.2 and stable at 1yr 14

15 © 2014 Virginia Mason ECD/KDPI >85% 15 Hefty et al. Urology, 1998

16 © 2014 Virginia Mason ECD/KDPI >85% 1.5 to 3 year wait time 98% overall graft survival last 5y 87.0%; 61.7%; 30.5% - 1, 3, and 5 yr survival nationwide Creation of local expedited placement list 16 SRTR Data

Download ppt "Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015."

Similar presentations

UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.

UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.
OPTN Regional Meetings Data Update Spring 2008. OPTN 2007 Donor, Transplant, and Waiting List Numbers.

OPTN Regional Meetings Data Update Spring OPTN 2007 Donor, Transplant, and Waiting List Numbers.
Ken Andreoni, MD Chair UNOS Kidney Comm The Ohio State University

Ken Andreoni, MD Chair UNOS Kidney Comm The Ohio State University
David Taber, Charles Bratton, Angello Lin, John McGillicuddy, Kenneth Chavin and Prabhakar Baliga.

David Taber, Charles Bratton, Angello Lin, John McGillicuddy, Kenneth Chavin and Prabhakar Baliga.
The New Kidney Allocation System: What Referring Physicians Need to Know The OPTN presents: The New Kidney Allocation System: What Referring Physicians.

The New Kidney Allocation System: What Referring Physicians Need to Know The OPTN presents: The New Kidney Allocation System: What Referring Physicians.
SRTR Transplant Benefit-Based Liver Allocation Robert M. Merion, MD, FACS OPTN/UNOS Liver Forum Atlanta, GA April 12, 2010.

SRTR Transplant Benefit-Based Liver Allocation Robert M. Merion, MD, FACS OPTN/UNOS Liver Forum Atlanta, GA April 12, 2010.
Kidney Transplantation Committee Update John J. Friedewald, MD Committee Chair Meetings.

Kidney Transplantation Committee Update John J. Friedewald, MD Committee Chair Meetings.
Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.

Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
Basics of Organ Transplantation Lon Eskind, MD Director Liver Transplant, CMC Assoc. Medical Director of LifeShare.

Basics of Organ Transplantation Lon Eskind, MD Director Liver Transplant, CMC Assoc. Medical Director of LifeShare.
DIALYSIS OR TRANSPLANTATION Ahmed Halawa MDSC175: Transplantation Science for Transplant Clinicians (Online) POSTGRADUATE SCHOOL OF MEDICINE A MEMBER OF.

DIALYSIS OR TRANSPLANTATION Ahmed Halawa MDSC175: Transplantation Science for Transplant Clinicians (Online) POSTGRADUATE SCHOOL OF MEDICINE A MEMBER OF.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition TRANSPLANT WAITING LIST CHAPTER 7.

ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition TRANSPLANT WAITING LIST CHAPTER 7.
Northwestern University Feinberg School of Medicine New Trends in organ donation and Transplantation Juan Carlos Caicedo, MD FACS Director, Hispanic Transplant.

Northwestern University Feinberg School of Medicine New Trends in organ donation and Transplantation Juan Carlos Caicedo, MD FACS Director, Hispanic Transplant.
AN ANALYSIS OF CADAVER DONOR AND KIDNEY BIOPSY PARAMETERS WITH CORRELATION TO TRANSPLANT OUTCOMES Martin Mozes MD, Mel Schwartz MD, Janis Orlowski MD Michael.

AN ANALYSIS OF CADAVER DONOR AND KIDNEY BIOPSY PARAMETERS WITH CORRELATION TO TRANSPLANT OUTCOMES Martin Mozes MD, Mel Schwartz MD, Janis Orlowski MD Michael.
Desensibilização em transplante renal – experiência da PUCRS (relato de caso) HOSPITAL SÃO LUCAS DA PUCRS SERVIÇO DE NEFROLOGIA 2012 David Saitovitch.

Desensibilização em transplante renal – experiência da PUCRS (relato de caso) HOSPITAL SÃO LUCAS DA PUCRS SERVIÇO DE NEFROLOGIA 2012 David Saitovitch.
Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients Deirdre Sawinski MD, Kimberly A.

Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients Deirdre Sawinski MD, Kimberly A.
What makes a pancreas allograft marginal? Peter J Friend University of Oxford.

What makes a pancreas allograft marginal? Peter J Friend University of Oxford.
Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.

Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.

USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
The Deceased Donor Kidney Allocation System

The Deceased Donor Kidney Allocation System
Facing the Organ Shortage Crisis: Business as Usual vs Non- Conventional Solutions? Richard Perez MD Division of Transplant Surgery UC Davis Medical Center.

Facing the Organ Shortage Crisis: Business as Usual vs Non- Conventional Solutions? Richard Perez MD Division of Transplant Surgery UC Davis Medical Center.

Similar presentations

Ads by Google